Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation on chromosome 13q33-q34 deletion syndrome is limited primarily due to its rarity and the absence of systematic clinical studies. Because this condition affects a small number of individuals, detailed research and characterization have not been extensively pursued. Additionally, the lack of identified genes associated with the syndrome further complicates understanding and documentation. However, ongoing research in related areas may provide future insights.
The clinical picture of chromosome 13q33-q34 deletion syndrome includes several key features. Hypertelorism, epicanthus, and hypotonia are consistently observed in all affected individuals. Other notable features, present in 80-99% of cases, include trigonocephaly, a wide nasal bridge, and strabismus. Additionally, some individuals may exhibit a tented upper lip vermilion, an open mouth, and posteriorly rotated ears. Growth may also be affected, with many individuals being small for gestational age. These features highlight the diverse manifestations of the syndrome.
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Actionable guidance for navigating care for chromosome 13q33-q34 deletion syndrome
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on chromosome 13q33-q34 deletion syndrome is limited primarily due to its rarity and the absence of systematic clinical studies. Because this condition affects a small number of individuals, detailed research and characterization have not been extensively pursued. Additionally, the lack of identified genes associated with the syndrome further complicates understanding and documentation. However, ongoing research in related areas may provide future insights.
The clinical picture of chromosome 13q33-q34 deletion syndrome includes several key features. Hypertelorism, epicanthus, and hypotonia are consistently observed in all affected individuals. Other notable features, present in 80-99% of cases, include trigonocephaly, a wide nasal bridge, and strabismus. Additionally, some individuals may exhibit a tented upper lip vermilion, an open mouth, and posteriorly rotated ears. Growth may also be affected, with many individuals being small for gestational age. These features highlight the diverse manifestations of the syndrome.
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Actionable guidance for navigating care for chromosome 13q33-q34 deletion syndrome
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on chromosome 13q33-q34 deletion syndrome is limited primarily due to its rarity and the absence of systematic clinical studies. Because this condition affects a small number of individuals, detailed research and characterization have not been extensively pursued. Additionally, the lack of identified genes associated with the syndrome further complicates understanding and documentation. However, ongoing research in related areas may provide future insights.
The clinical picture of chromosome 13q33-q34 deletion syndrome includes several key features. Hypertelorism, epicanthus, and hypotonia are consistently observed in all affected individuals. Other notable features, present in 80-99% of cases, include trigonocephaly, a wide nasal bridge, and strabismus. Additionally, some individuals may exhibit a tented upper lip vermilion, an open mouth, and posteriorly rotated ears. Growth may also be affected, with many individuals being small for gestational age. These features highlight the diverse manifestations of the syndrome.
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Actionable guidance for navigating care for chromosome 13q33-q34 deletion syndrome
To navigate your journey with chromosome 13q33-q34 deletion syndrome, consider consulting with a geneticist or a pediatrician who specializes in genetic disorders. These specialists can provide insights into the condition and guide you through potential management strategies. While there are currently no specific patient organizations for this syndrome, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can be helpful for finding additional information and support. Genetic counseling may also be beneficial, especially for family planning and understanding inheritance patterns.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.